Results 171 to 180 of about 533,514 (236)

Discovery of [1,2,4]triazolo[1,5‐a]pyrimidine‐Imatinib Hybrids With Selective Cytotoxic Activity: A Mechanistically Divergent Series From Direct BCR‐ABL1 Inhibition

open access: yesChemMedChem, Volume 21, Issue 8, 28 April 2026.
Discovery of imatinib–triazolopyrimidine hybrids with selective cytotoxicity and a mechanism distinct from classical BCR‐ABL1 inhibition. This bioisosteric strategy introduces a novel compounds, paving the way for innovative antileukemic therapies with differentiated profiles.
Stefany Castro Bazan Moura   +10 more
wiley   +1 more source

Assessment of culture of care in health services: a scoping review protocol. [PDF]

open access: yesBMJ Open
Paulino FLN   +3 more
europepmc   +1 more source

[Variability in patient safety culture at Brazilian hospitals: influence of contextual factors]. [PDF]

open access: yesCad Saude Publica
Gama ZADS   +9 more
europepmc   +1 more source

Raising Awareness about Continuing Health Education with Nursing Professionals: Strategic Action Research. [PDF]

open access: yesRev Bras Enferm
Silva CRFD   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy